Adressed challenge/PPP

Slides:

Advertisements

Similar presentations

Project title / Field of expertise Adressed challenge/PPP Adressed topic in working programme Thematic brokerage workshops EU Brokerage Event on Kets in.

Advertisements

ON HEART TISSUE REENGINEERING ? JC Chachques, MD PhD Georges Pompidou European Hospital Paris, France Stem cell therapy and CV innovations What’s new ?

Research perspectives on nanotechnology and society based on session 3 and workshop on: The limits of nanotechnology and beyond 1)Regulation of risks and.

Project title / Field of expertise Adressed challenge/PPP Adressed topic in working programme Thematic brokerage workshops EU Brokerage Event on Kets in.

Since 1994 KSMU has actively taken part in clinical medical trials in I-IV phases (certificate of accreditation for conducting clinical trials of medications.

Left Ventricular Assist Devices: The What and the Who Lance E. Sullenberger MD FACC FACP Capital Cardiology Associates.

Proposal for a European Faculty of Regenerative Medicine ScanBalt Campus Knowledge centers.

Challenge and Innovation in Cardiovascular Therapeutics: 1st Annual BHF Centre Symposium Michael D. Schneider MD FMedSci Head, National Heart and Lung.

The Structural Heart Disease Program your partners for advanced interventional cardiology Structural Heart Disease is a new branch of cardiology involving.

Since 1994 KSMU actively involved in clinical medical trials in I-IV phases (certificate of accreditation for conducting clinical trials of medicinal products.

Why should a cardiology fellow get in the field of iCMR ? Mounir RIAHI, MD. Montreal Heart Institute at Interventional cardiac magnetic resonance workshop,

1 E NHANCING THE BODY ’ S NATURAL H EALING AND R EGENERATIVE R ESOURCES.

Heart Failure (HF) : Overview Common underlying heart diseases or causes of HF 1.Valvular HD-Rheumatic etiology 2.Cardiomyopathy – Dilated type 3.Ischemic.

Thematic Pitch Sessions EU Brokerage Event on Advanced Manufacturing Horizon 2020 Nantes, 24 June Field of expertise Adressed Work Programme(s)

MEDTRONIC Fall Foundations 2014 | Business Acumen.

Biotechnology A collection of techniques that use living cells to make products or solve problems.

Current Areas of NIBIB Space-Related Health Research Image-Guided Surgery Image-Guided Surgery Point-of-Care Technology Point-of-Care Technology Multi-Scale.

GRK2 Inhibition Reduces Post-Myocardial Infarction Cardiac Fibroblast-Mediated Adverse Remodeling Jennifer L. Philip 1, Xianyao Xu 1,Mei Han 1, Jinju Li.

Supporting Network in the Baltic Candidate Countries Partnering Meeting in Birini, Presented by Zygmunt Krasiński NBCC Project manager Zygmunt.

IN THE NAME OF GOD. What are Stem Cells? Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types.

Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Assessment of the area at risk after acute myocardial infarction.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

Organization Name Surname

ST T CHANGES Dr SRIKANTH KV MD DM ( CARDIOLOGY) SENIOR INTERVENTIONAL CARDIOLOGIST Specialist in Heart Failure Narayana Institute of Cardiac Sciences.

University of Chicago Medicine

Ventricular function recovery on LVAD For idiopathic or ischemic CM

Chapter 24, Future Design Issues

Prof. Rui L. Reis, CEng, MSc, PhD, DSc, MD (Doctor h

FP7 Experience (Collaborative Project Application)

Project title / Field of expertise Adressed topic in working programme

Thematic Brokerage Workshops

The STICH trial: Misguided conclusions

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Objectives: Expected results:

Stem cell therapy in the aging hearts of Fisher 344 rats: Synergistic effects on myogenesis and angiogenesis Jiang-Yong Min, MD, Yu Chen, MD, Sohail.

John E. Sanderson JCHF 2014;2:93-94

Building a bioartificial heart: A 3-song saga

Preventing cardiac remodeling: The combination of cell-based therapy and cardiac support therapy preserves left ventricular function in rodent model of.

Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle Theo Kofidis, MD,

Organization Name Surname

Suyog A. Mokashi, MD, Lawrence S. Lee, MD, Jan D

Thematic Brokerage Workshops

Ventricular Dilatation and Remodeling After Myocardial Infarction

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Discussions in Cardiothoracic Treatment and Care: Mechanical Circulatory Support Left Ventricular Assist Device Therapy for Patients With Advanced Heart.

Congestive heart failure: Treat the disease, not the symptom

TP1 and TP5 Brokerage Event, Paris, May 31st 2005

Smart Solar Power in Europe

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

Targeted topics (EEB; B4E; EC; ES; SCC)

Cellular therapy reverses myocardial dysfunction

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L.

Passive epicardial containment prevents ventricular remodeling in heart failure Pervaiz A Chaudhry, MD, Takayuki Mishima, MD, Victor G Sharov, MD, James.

Smart Solar Power in Europe

Association of electrostimulation with cell transplantation in ischemic heart disease Abdel Shafy, MD, Thomas Lavergne, MD, Christian Latremouille, MD,

Possible topic/topics (edit) Keywords TITLE Your Name Organization

Eduardo Marbán, MD, PhD Mayo Clinic Proceedings

Please insert text here

Title of presentation* + the topic(s) of interest

Please insert text here

Organization Name Surname

Dynamic cardiomyoplasty: at the crossroads

Clinical case report platform

The role of a defined protocol for cardiac risk assessment in decreasing perioperative myocardial infarction in vascular surgery T.J. Bunt, MD Journal.

Optimized ventricular restraint therapy: Adjustable restraint is superior to standard restraint in an ovine model of ischemic cardiomyopathy Lawrence.

Jeffrey Senfield et al. JACEP 2017;3:

Annetine C. Gelijns, PhD, Alexandra F. Richards, BS, Deborah L

β-Blocker Use for the Stages of Heart Failure

Presentation transcript:

Adressed challenge/PPP Heart Failure Therapy. Tissue engineering. Nano-Biotechnologies Laboratory of Biosurgical Research. Pompidou Hospital, University of Paris, FR Create Ventricular support bioprostheses & Bioartificial myocardium to avoid Heart Tx Biomimetic approaches to control epidemic heart failure. Ventricular remodeling devices 02/05/2016 - BE KETs Adressed challenge/PPP

Thematic Brokerage Workshops Pompidou Hospital Cardiac Bioassist 12/05/2015 - BE KETs Thematic Brokerage Workshops

Conical to spherical shape in HF Bioprostheses for heart support Cardiopatch for myocardial infarct Helical loop to restore conical shape 12/05/2015 - BE KETs Thematic Brokerage Workshops

Known partners / Competence offer Name Type Country Role in the project Lab. Biosurgical Research Univ. France Cardiac Surgery, Interventional Cardiology, Biotechnologies Fraunhofer Institute IBMT Germany Biomedical Engineering Partner search Profile Nanobiotechnology Creation preclinical and clinical prototypes Imaging and monitoring technologies Nanotechnologies for imaging cellular transplants and regenerative processes in vivo 12/05/2015 - BE KETs Thematic Brokerage Workshops

Thematic Brokerage Workshops Contact Person Juan Carlos Chachques, MD, PhD Organisation Laboratory Biosurgical Research, Pompidou Hospital Adress 56 rue Leblanc. 75015 Paris. France Telephone +33156095905 +33613144398 E-mail j.chachques@aphp.fr 12/05/2015 - BE KETs Thematic Brokerage Workshops